Keyphrases
Gout
100%
Serum Urate
100%
Urate-lowering Therapy
100%
Randomized Double-blind Controlled Trial
100%
Bone Erosion
50%
Computed Tomography
25%
Between-group Difference
25%
OMERACT
25%
Allopurinol
25%
Core Outcome Domains
25%
Serum Urate Levels
25%
Combination Therapy
12%
Health-related Quality of Life
12%
Therapeutic Approaches
12%
Double-blind Randomized Controlled Trial
12%
Adverse Events
12%
High Dose
12%
Activity Limitations
12%
Pain Patients
12%
Disease Activity Score
12%
Serious Adverse Events
12%
Rheumatology
12%
Medication Burden
12%
Life-limiting
12%
Probenecid
12%
Adverse Event Rates
12%
Outcome Measures in Rheumatology
12%
Tophi
12%
Patient Global Assessment
12%
Febuxostat
12%
Gout Flare
12%
Benzbromarone
12%
Medicine and Dentistry
Gout
100%
Urate
100%
Oral
100%
Bone Erosion
33%
Adverse Event
16%
Computer Assisted Tomography
16%
Rheumatology
16%
Allopurinol
16%
Quality of Life
8%
Combination Therapy
8%
Randomized Controlled Trial
8%
Disease Activity
8%
Drug Megadose
8%
Probenecid
8%
Tophus
8%
Febuxostat
8%
Benzbromarone
8%
Pharmacology, Toxicology and Pharmaceutical Science
Gout
100%
Urate
100%
Bone Erosion
33%
Adverse Event
16%
Allopurinol
16%
Combination Therapy
8%
Randomized Controlled Trial
8%
Disease Activity
8%
Probenecid
8%
Benzbromarone
8%
Febuxostat
8%